Abstract
The lower matrix protein (pp65) is a major product of many laboratory strains of cytomegalovirus (CMV). It is thus an integral part of many CMV serological assays based on native antigen. Recombinant fragments of pp65 have previously been investigated for their usefulness in more-defined assays. The latter antigens have, however, failed to develop a positive response with serum samples derived from a substantial number of infected individuals. Here we show that the human humoral immune response to CMV pp65 is highly diverse and recognizes at least seven distinct but in some cases partly overlapping epitopes. Most of these epitopes could not be mimicked by any of the investigated recombinant or synthetic antigens. Furthermore, when we investigated the ability of human CMV-seropositive serum samples to block the reactivity of pp65-specific antibodies recognizing five different epitopes within pp65, it was evident that several sera did not contain significant levels of antibodies against any of these or overlapping structures. It was thus concluded that the antibody response against CMV pp65 is weak in some CMV-infected individuals, making this antigen unsuitable for use alone in serological screening systems for CMV infection.
References
Jan 1, 1992·Journal of Clinical Microbiology·B PlachterG Jahn
Feb 1, 1992·The Journal of General Virology·M G RevelloG Gerna
Nov 1, 1992·The Journal of General Virology·J M GrefteT H The
Jun 1, 1990·Journal of Clinical Microbiology·M P LandiniB Plachter
Jan 1, 1990·Archives of Virology·W LindenmaierJ Collins
Aug 7, 1990·Journal of Immunological Methods·T TomiyamaY Masuho
May 1, 1991·Virology·H PandeJ A Zaia
Jun 1, 1990·Journal of Clinical Microbiology·B PlachterG Jahn
Dec 1, 1985·Journal of Virological Methods·P LjungmanV A Sundqvist
Dec 1, 1985·Journal of Medical Virology·M P LandiniM La Placa
Apr 1, 1986·The Journal of Infectious Diseases·J A ZaiaK G Blume
Sep 1, 1986·Journal of Clinical Microbiology·J M MiddeldorpT H The
Feb 1, 1987·Journal of Virology·B RügerB Barrell
May 1, 1987·The Journal of General Virology·G JahnB Fleckenstein
Oct 1, 1987·The Journal of Infectious Diseases·K HayesW Britt
Oct 15, 1983·Virology·A Irmiere, W Gibson
Sep 1, 1994·Journal of Medical Virology·C Y ShenC W Wu
Apr 1, 1994·Journal of Clinical Microbiology·R VornhagenG Jahn
Jan 1, 1993·Journal of Medical Virology·J van ZantenT H The
Citations
May 25, 2002·Scandinavian Journal of Immunology·G Gallez-HawkinsJ A Zaia
Nov 22, 2018·Scientific Reports·Qingda MengMarkus Maeurer
Apr 12, 2005·Nature Immunology·Tal I ArnonOfer Mandelboim
Jun 14, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mattias LevinMats Ohlin
Mar 11, 2006·The Journal of General Virology·Yujuan YuePeter A Barry
Feb 13, 2001·Vaccine·Z Q YaoJ A Zaia
Dec 17, 1998·Journal of Clinical Microbiology·A E GreijerJ M Middeldorp